College of Pharmacy, University of Arizona , Tucson, Arizona 85721, United States.
BIO5 Institute, University of Arizona , Tucson, Arizona 85721, United States.
J Am Chem Soc. 2017 Jun 28;139(25):8522-8536. doi: 10.1021/jacs.7b02046. Epub 2017 Jun 15.
Activating KRAS mutations frequently occur in pancreatic, colorectal, and lung adenocarcinomas. While many attempts have been made to target oncogenic KRAS, no clinically useful therapies currently exist. Most efforts to target KRAS have focused on inhibiting the mutant protein; a less explored approach involves targeting KRAS at the transcriptional level. The promoter element of the KRAS gene contains a GC-rich nuclease hypersensitive site with three potential DNA secondary structure-forming regions. These are referred to as the Near-, Mid-, and Far-regions, on the basis of their proximity to the transcription start site. As a result of transcription-induced negative superhelicity, these regions can open up to form unique DNA secondary structures: G-quadruplexes on the G-rich strand and i-motifs on the C-rich strand. While the G-quadruplexes have been well characterized, the i-motifs have not been investigated as thoroughly. Here we show that the i-motif that forms in the C-rich Mid-region is the most stable and exists in a dynamic equilibrium with a hybrid i-motif/hairpin species and an unfolded hairpin species. The transcription factor heterogeneous nuclear ribonucleoprotein K (hnRNP K) was found to bind selectively to the i-motif species and to positively modulate KRAS transcription. Additionally, we identified a benzophenanthridine alkaloid that dissipates the hairpin species and destabilizes the interaction of hnRNP K with the Mid-region i-motif. This same compound stabilizes the three existing KRAS G-quadruplexes. The combined effect of the compound on the Mid-region i-motif and the G-quadruplexes leads to downregulation of KRAS gene expression. This dual i-motif/G-quadruplex-interactive compound presents a new mechanism to modulate gene expression.
KRAS 突变在胰腺、结直肠和肺腺癌中经常发生。尽管已经有许多尝试靶向致癌性 KRAS,但目前尚无临床有效的疗法。大多数靶向 KRAS 的努力都集中在抑制突变蛋白上;一种探索较少的方法是在转录水平靶向 KRAS。KRAS 基因的启动子元件包含富含 GC 的核酸酶超敏位点,具有三个潜在的 DNA 二级结构形成区域。这些区域根据其与转录起始位点的接近程度,分别称为近区、中区和远区。由于转录诱导的负超螺旋,这些区域可以打开形成独特的 DNA 二级结构:富含 G 的链上的 G-四联体和富含 C 的链上的 i- 发夹。虽然 G-四联体已经得到了很好的描述,但 i- 发夹尚未得到充分研究。在这里,我们表明,在富含 C 的中区形成的 i- 发夹是最稳定的,并且与杂交 i- 发夹/发夹物种和未折叠发夹物种处于动态平衡中。异质核核糖核蛋白 K (hnRNP K) 转录因子被发现选择性地结合到 i- 发夹物种上,并正向调节 KRAS 转录。此外,我们鉴定了一种苯并菲啶生物碱,它可以消散发夹物种并破坏 hnRNP K 与中区 i- 发夹的相互作用。该化合物还稳定了现有的三个 KRAS G-四联体。该化合物对中区 i- 发夹和 G-四联体的综合作用导致 KRAS 基因表达下调。这种双重 i- 发夹/ G-四联体相互作用化合物提供了一种调节基因表达的新机制。